Results 121 to 130 of about 1,978 (184)

We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe.

PLoS ONE
With new pre-exposure prophylaxis (PrEP) modalities for HIV prevention becoming available, understanding how adolescent girls and young women (AGYW) navigate through PrEP options is essential, including factors underlying their choice.
Millicent Atujuna, Kristin Williams, Sarah T Roberts, Alinda Young, Erica N Browne, Nomvuyo T Mangxilana, Siyanda Tenza, Mary Kate Shapley-Quinn, Thelma Tauya, Kenneth Ngure, Ariane van der Straten   +10 more
doaj   +1 more source

The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage development

Frontiers in Reproductive Health
Product development is a high-risk undertaking, especially so when investments are prioritized for low- and middle-income countries (LMICs) where markets may be smaller, fragile, and resource-constrained.
Katerina Chapman, Sergio Torres-Rueda, Mutsumi Metzler, Bethany Young Holt, Elijah Kahn-Woods, Douglas Thornton, Gabriela B. Gomez, Gabriela B. Gomez   +7 more
doaj   +1 more source

Achieving HIV epidemic control through accelerating efforts to expand access to pre-exposure prophylaxis for people who inject drugs

Frontiers in Reproductive Health
The world is not on track to reach the majority of the UNAIDS 2025 targets, and people who inject drugs (PWID) continue to be left behind, hindered by counterproductive law enforcement practices, punitive laws, economic distress, and social stigma and ...
Lirica Nishimoto, Adaobi Lisa Olisa, Philip Imohi, Judy Chang, Chris Obermeyer, Dama Kabwali, Christopher Akolo   +6 more
doaj   +1 more source

Freeze-dried, mucoadhesive system for vaginal delivery of the HIV microbicide, dapivirine: optimisation by an artificial neural network [PDF]

, 2010
Kett, Victoria L., Malcolm, R. Karl, Umrethia, Manish L., Woolfson, A. David   +3 more
core   +1 more source

Microbicide Vaginal Rings: Technological Challenges and Clinical Development [PDF]

, 2016
Boyd, Peter J., Malcolm, R. Karl, McCoy, Clare F., Murphy, Diarmaid J.   +3 more
core   +1 more source

Abstract Supplement Abstracts from IAS 2025, the 13th IAS Conference on HIV Science, 13 – 17 July, Kigali, Rwanda & Virtual

Journal of the International AIDS Society, Volume 28, Issue S4, July 2025.
wiley   +1 more source

Intravaginal immunization using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses [PDF]

, 2017
Aldon, Yoann, Kett, Vicky, King, Deborah, Malcolm, R Karl, Mann, Jamie F S, McKay, Paul F, Pattani, Aditya, Shattock, Robin J   +7 more
core   +1 more source

Contents

Journal of the International AIDS Society, Volume 28, Issue S2, July 2025.
wiley   +1 more source

J Infect Dis [PDF]

High rates of tuberculosis transmission are driving the ongoing global tuberculosis epidemic, and there is a pressing need for research focused on understanding and, ultimately, halting transmission. The ongoing tuberculosis-human immunodeficiency virus (

core  

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes

Drug Design, Development and Therapy, 2017
Fernando Notario-Pérez, Roberto Ruiz-Caro, María-Dolores Veiga-Ochoa Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain Abstract: Infection with human ...
Notario-Pérez F, Ruiz-Caro R, Veiga-Ochoa MD   +2 more
doaj